Assembly biosciences reports inducement grant under nasdaq listing rule 5635(c)(4)

South san francisco, calif., april 01, 2022 (globe newswire) -- assembly biosciences, inc. (nasdaq: asmb), a clinical-stage biotechnology company developing innovative therapeutics targeting hepatitis b virus (hbv) and other viral diseases, today announced a grant of stock options to one new employee to purchase 19,000 shares of the company's common stock with an exercise price of $2.06 per share, the closing price of assembly bio's common stock on april 1, 2022. the stock options were granted as a material inducement to new employee to accept the company's offer of employment.
ASMB Ratings Summary
ASMB Quant Ranking